Don’t expect the US government’s war on drug pricing to go away any time soon – for once president Trump and his rivals, the Democrat party, agree on something, and both have had some stron
Market access has become a key focus for governments across the globe in 2018 – though as ever a balance between what is good for the industry and what is good for countries and their healt
The deadline for Brexit is edging closer, and politicians in the UK are struggling to come to terms with the deal that prime minister Theresa May has negotiated with her European counterparts.<
